Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C48636> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- NCIT_C48636 IAO_0000115 "A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. E7080 blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis." @default.
- NCIT_C48636 NCIT_A32 NCIT_C1909 @default.
- NCIT_C48636 NCIT_A6 NCIT_C95124 @default.
- NCIT_C48636 NCIT_A7 NCIT_C28496 @default.
- NCIT_C48636 NCIT_NHC0 "C48636" @default.
- NCIT_C48636 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C48636 NCIT_P107 "Lenvatinib Mesylate" @default.
- NCIT_C48636 NCIT_P108 "Lenvatinib Mesylate" @default.
- NCIT_C48636 NCIT_P171 "18765537" @default.
- NCIT_C48636 NCIT_P207 "C4018332" @default.
- NCIT_C48636 NCIT_P210 "857890-39-2" @default.
- NCIT_C48636 NCIT_P302 "locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer; advanced renal cell carcinoma (RCC); first-line treatment of patients with unresectable hepatocellular carcinoma (HCC)." @default.
- NCIT_C48636 NCIT_P319 "3J78384F61" @default.
- NCIT_C48636 NCIT_P322 "CTRP" @default.
- NCIT_C48636 NCIT_P322 "FDA" @default.
- NCIT_C48636 NCIT_P322 "GDC" @default.
- NCIT_C48636 NCIT_P329 "445461" @default.
- NCIT_C48636 NCIT_P330 "445461" @default.
- NCIT_C48636 NCIT_P350 "C21H19ClN4O4.CH4O3S" @default.
- NCIT_C48636 NCIT_P366 "E7080" @default.
- NCIT_C48636 NCIT_P375 "Lenvatinib Mesylate" @default.
- NCIT_C48636 NCIT_P399 "445461" @default.
- NCIT_C48636 normalizedInformationContent "92.730304365937428" @default.
- NCIT_C48636 referenceCount "3" @default.
- NCIT_C48636 hasExactSynonym "4-[3-Chloro-4-(N'-cyclopropylureido)phenoxy]7-methoxyquinoline-6-carboxamide Mesylate" @default.
- NCIT_C48636 hasExactSynonym "6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]- 7-methoxy-, methanesulfonate (1:1)" @default.
- NCIT_C48636 hasExactSynonym "E7080 Mesylate" @default.
- NCIT_C48636 hasExactSynonym "LENVATINIB MESYLATE" @default.
- NCIT_C48636 hasExactSynonym "Lenvatinib Mesylate" @default.
- NCIT_C48636 hasExactSynonym "Lenvima" @default.
- NCIT_C48636 hasExactSynonym "Multi-Kinase Inhibitor E7080 Mesylate" @default.
- NCIT_C48636 inSubset NCIT_C116977 @default.
- NCIT_C48636 inSubset NCIT_C116978 @default.
- NCIT_C48636 inSubset NCIT_C128784 @default.
- NCIT_C48636 inSubset NCIT_C157711 @default.
- NCIT_C48636 inSubset NCIT_C157712 @default.
- NCIT_C48636 inSubset NCIT_C176424 @default.
- NCIT_C48636 inSubset NCIT_C177537 @default.
- NCIT_C48636 inSubset NCIT_C63923 @default.
- NCIT_C48636 type Class @default.
- NCIT_C48636 isDefinedBy ncit.owl @default.
- NCIT_C48636 label "Lenvatinib Mesylate" @default.
- NCIT_C48636 subClassOf NCIT_C129824 @default.
- NCIT_C48636 subClassOf NCIT_C129825 @default.
- NCIT_C48636 subClassOf NCIT_C1404 @default.
- NCIT_C48636 subClassOf NCIT_C163758 @default.
- NCIT_C48636 subClassOf NCIT_C163953 @default.
- NCIT_C48636 subClassOf NCIT_C1742 @default.
- NCIT_C48636 subClassOf NCIT_C1908 @default.
- NCIT_C48636 subClassOf NCIT_C1909 @default.
- NCIT_C48636 subClassOf NCIT_C1967 @default.
- NCIT_C48636 subClassOf NCIT_C2189 @default.
- NCIT_C48636 subClassOf NCIT_C274 @default.
- NCIT_C48636 subClassOf NCIT_C471 @default.
- NCIT_C48636 subClassOf NCIT_C48636 @default.
- NCIT_C48636 subClassOf NCIT_C93259 @default.